Suchergebnisse - "Davis, Hugh"

PubPharm (7)

1

Dose selection of siltuximab for multicentric Castleman's disease

enthalten in: Cancer chemotherapy and pharmacology | 2015

von Mayer, C. | Xie, L. | Bandekar, R. | +6

2

A phase 1, randomized study to assess the pharmacokinetic comparability of siltuximab derived from two different cell lines in healthy subjects

enthalten in: Clinical pharmacology in drug development | 2014

von Xu, C. | Han, C. | Marini, J. | +9

3

Mechanistic pharmacokinetic/target engagement/pharmacodynamic (PK/TE/PD) modeling in deciphering interplay between a monoclonal antibody and its soluble target in cynomolgus monkeys

enthalten in: The AAPS journal | 2014

von Wang, W. | Wang, X. | Doddareddy, R. | +4

4

A novel approach to evaluate the pharmacokinetic biocomparability of a monoclonal antibody derived from two different cell lines using simultaneous crossover design

enthalten in: The AAPS journal | 2014

von Han, C. | McIntosh, T. | Geist, B. | +7

5

A novel approach for the simultaneous quantification of a therapeutic monoclonal antibody in serum produced from two distinct host cell lines

enthalten in: mAbs | 2013

von Geist, B. | Davis, D. | McIntosh, T. | +5

6

Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study

enthalten in: British journal of clinical pharmacology | 2011

von Xu, Z. | Bouman-Thio, E. | Comisar, C. | +5

7

Pharmacokinetic and pharmacodynamic modeling of an anti-interleukin-6 chimeric monoclonal antibody (siltuximab) in patients with metastatic renal cell carcinoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Puchalski, T. | Prabhakar, U. | Jiao, Q. | +2

1
[1]